The University of Pittsburgh HRP established fees to help fund services provided by the Institutional Review Board (IRB), Institutional Biosafety Committee (IBC), and Radiation Safety, Human Use Sub Committee (HUSC). Fees are charged for industry-sponsored research and research where Pitt is the Single IRB for external federally-funded sites conducting non-exempt human subjects research.
Industry-Sponsored Research
Fees for industry-sponsored research cover the real cost associated with protocol review by the IRB, IBC, and HUSC. If subjects are never enrolled, the study terminates before milestones are met, expenditures exceed revenue, or a contract is never finalized, the investigator and department are responsible for all expenditures not covered by the sponsor, including IRB fees. Studies will not be reviewed until the fee is paid.
A fee waiver can be requested under limited circumstances:
-
The only support being provided by the industry-sponsor is the provision of a drug or device
-
The industry support is less than $15,000
The waiver is subject to approval by the Director of Administrative Support.
Pitt IRB as the Single IRB (sIRB) for a Multi-Site Study
The IRB is permitted to charge fees for studies where Pitt is serving as the IRB of Record for multiple research locations. A request for a budget must be submitted through the Reliance Request System prior to grant submission. The fees are based upon the number of relying sites, and number of years for the grant. A fee waiver can be requested under limited circumstances:
- There may be circumstances when sIRB fees were not budgeted into the initial grant application. With confirmation from the funding agency that the budget cannot be amended, an alteration or waiver of the fees can be requested. However, it may not be approved in which case the request for Pitt to serve as IRB of Record may be declined.
The waiver is subject to approval by the Reliance Team.
Billing Information
A fee sheet with the appropriate charges marked should be uploaded into PittPRO on the funding source page at the time of submission to the IRB. It is important that all applicable sections are completed to avoid delays in processing.Fee Schedule — Industry-Sponsored Studies
| Review Type | Full Board | Expedited | Exempt |
|---|---|---|---|
| Initial Application | $3,000 | $3,000 | $1,000 |
| Institutional Biosafety Committee (IBC) | $2,500 one-time fee — effective July 1, 2026 | ||
| Radiation Safety Human Use Subcommittee (HUSC) | $2,000 one-time fee — effective July 1, 2026 | ||
| Continuing Review | $2,000 | $1,500 | N/A |
| Study-Wide Sponsor-Initiated Amendment | $1,000 | $1,000 | $1,000 |
| Study Close-Out | $600 | $600 | $600 |
| Ceded Study Reviewed by Commercial IRB | $2,500 one-time fee — in addition to fees charged by the commercial IRB | ||
Continuing Review: $1,500 Full Board / $1,500 Expedited / N/A Exempt
Fee Schedule — Pitt as IRB of Record
Do not include Pitt/UPMC sites in the number of sites.
| Onboarding Relying Sites | $2,100 × number of relying sites |
| Continuing Review | $250 × number of relying sites |
| Study-Wide Amendments | $400 × number of relying sites |
Do not include Pitt/UPMC sites in the number of sites.
| Fee Type | Full Board | Expedited |
|---|---|---|
| Initial Application / Modifications for the first year | $1,750 | $3,000 |
| Onboarding Relying Sites | $2,000 per site | $1,000 per site |
| Continuing Review / Modifications for the next year | $2,750 | $2,250 |